×
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

Coronavirus vaccine news highlights: Serum moves 56 lakh Covishield doses; Bharat Biotech transports Covaxin 16.5 lakh doses

The Centre expects to receive all 1.65 crore doses of Covid-19 vaccine it had ordered from two manufacturers by Thursday, well in time to start the massive vaccination drive on Saturday, Jan 16. The Centre has ordered 1.1 crore doses of Covishield from the Serum Institute and 55 lakh doses of Covaxin developed by homegrown vaccine maker Bharat Biotech. Meanwhile, Chinese vaccine Coronavac has shown 50% efficacy in Brazil and the US has ramped up its vaccination drive after cases and toll mounted.
Last Updated 14 January 2021, 03:32 IST
14:3013 Jan 2021

Five hurdles in the global Covid-19 vaccine rollout

The unprecedented push to inoculate the world's population against Covid-19 has got off to a sluggish start, triggering a storm of criticism.

Read more

14:2913 Jan 2021

India wants Pfizer to do local study for approval

Any vaccine maker, including Pfizer Inc, which has sought emergency-use authorisation for its Covid-19 shot in India, must conduct a local "bridging" safety and immunogenicity study to be considered for the country's immunisation programme, a senior government official told Reuters.

Read more

13:3713 Jan 2021

This is the initial lot of supply of vaccine doses and would be continuously replenished in the weeks to come. Therefore, any apprehension being expressed on account of deficient supply is totally baseless and unfounded: Ministry of Health

(ANI)

13:3613 Jan 2021

Full initial procurement amount of 1.65 cr doses of Covishield & Covaxin vaccines allocated to all States/UTs in the proportion of health care workers database. There is no question of discrimination against any State in the allocation of vaccine doses: Ministry of Health

(ANI)

(Published 13 January 2021, 02:56 IST)

Follow us on